The programme will be published soon
Wednesday, November 29, 2023
| Welcome |
| 4.30 pm-6.00 pm
|
| Chairs: Christophe D'enfert, Institut Pasteur, Paris, France - Sharon Lewin, Doherty Institute, Australia |
|
0
4.30 pm |
Opening
Stewart Cole
President, Institut Pasteur, Paris, France
|
|
0
4.40 pm |
Yazdan Yazdanpanah
Director of ANRS | EID, INSERM, Paris, France
|
|
0
4.50 pm |
Anne-Claire Amprou
Ambassadrice de France en charge des questions de santé mondiale
|
|
0
5.00 pm |
Communities and activists: from confrontation to partnership in research
Hugues Fischer
TRT5, Pantin, France
|
|
0
5.30 pm |
Introductory lecture: 40 Years of HIV Science: Much Accomplished, Much To Do
Anthony S. Fauci
Distinguished University Professor, Georgetown University School of Medicine, Department of Medicine, Bethesda, Maryland, United States
|
|
| Welcome Cocktail |
| 6.00 pm-7.30 pm
|
|
|
Thursday, November 30, 2023
| Session 1: Host cell-virus interactions |
| 09.00 am-10.20 am
|
| Chairs: Angela Ciuffi, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland - Frank Kirchhoff, Ulm University, Ulm, Germany |
|
0
09.00 am |
Structure and function of the HIV capsid
Wesley I. Sundquist
University of Utah, Salt Lake City, United States
|
|
0
09.20 am |
The Next Frontier: Breakthroughs in HIV Post-Nuclear Entry Research
Francesca Di Nunzio
Institut Pasteur, Paris, France
|
|
0
09.40 am |
Viral fusion and its inhibition
Olivier Schwartz
Institut Pasteur, Paris, France
|
|
0
10.00 am |
Molecular conflict between HIV and host restriction factors
Florence Margottin-Goguet
Institut Cochin, University of Paris Cité, INSERM U1016, CNRS UMR8104, Paris, France
|
|
| Coffee break |
| 10.20 am-10.50 am
|
|
|
| Session 2: Host responses to HIV infection |
| 10.50 am-12.10 pm
|
| Chairs: Michaela Müller-Trutwin, Institut Pasteur, Paris, France - Guido Silvestri, Emory University, Atlanta, United States |
|
0
10.50 am |
Sex differences in HIV-1 pathogenesis
Marcus Altfeld
Leibniz Institute of Virology, Leibniz, Germany
|
|
0
11.10 am |
Using Spatial Biology and Multi-Omics approaches to understand HIV Persistence in tissues
Zaza Ndhlovu
Harvard University, Cambridge, MA & University of KwaZulu-Natal, Durban, South Africa
|
|
0
11.30 am |
Exploring Broadly Neutralizing Antibodies for HIV-1 Therapy
Michel C. Nussenzweig
Rockefeller University, New York, United States
|
|
0
11.50 am |
NK cell differentation and viral control in SIV infection models
Nicolas Huot
Institut Pasteur, Université Paris-Cité, Unité HIV, Inflammation et Persistance, Paris, France
|
|
| Session 3: Social / implementation Sciences |
| 2.00 pm-3.20 pm
|
| Chair: Meg Doherty, World Health Organization, Geneva, Switzerland |
|
0
2.00 pm |
Don't pass me by - the person at the centre of HIV... (Zoom TBC)
Lorraine Sherr
University College London, United Kingdom
|
|
0
2.20 pm |
Clinical implementation of HIV discoveries
Beatriz Grinstejn
Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
|
|
0
2.40 pm |
Undoing Risk? Sociological Perspectives on HIV Prevention
Gabriel Girard
SESSTIM Inserm, Marseille, France
|
|
0
3.00 pm |
Transforming effective innovations into efficient interventions: contributions from social and implementation sciences
Joseph Larmarange
CEPED, Paris, France
|
|
| Coffee break |
| 3.20 pm-3.50 pm
|
|
|
| Session 4: Viral Persistence and Viral control |
| 3.50 pm-5.50 pm
|
| Chairs: Christine Rouzioux, University of Paris Descartes, Paris, France - Danny Douek, National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, United States |
|
0
3.50 pm |
HIV-1 Cure informed by Elite Controllers
Xu Yu
Ragon Institute of MGH, MIT and Harvard, Cambridge, United States
|
|
0
4.10 pm |
New insights into viral control
Asier Saez-Cirion
Institut Pasteur, Paris, France
|
|
0
4.30 pm |
Resident microbiota is a major driver of the acquisition and pathogenesis of HIV and EBV
J. Victor Garcia
The University of Alabama at Birmingham, Birmingham, United States
|
|
0
4.50 pm |
Non-T cell tissue niches for HIV reservoirs in human macrophages and megakaryocytes and their cross talk
Morgane Bomsel
Laboratory of Mucosal Entry of HIV and Mucosal Immunity, Institut Cochin, University of Paris Cité, CNRS, UMR8104, Inserm, U1016, Paris, France
|
|
0
5.10 pm |
The journey of HIV-1 DNA: From its synthesis to integration into the host genome
Monsef Benkirane
Human Genetics Institute, Montpellier, France
|
|
0
5.30 pm |
Human broadly neutralizing antibodies to HIV-1 and beyond
Hugo Mouquet
Institut Pasteur, Paris, France
|
|
Friday, December 1, 2023
| Session 5: HIV Prevention |
| 09.00 am-10.30 am
|
| Chairs: Roger Le Grand, IDMIT, CEA, Fontenay-Aux-Roses, France - Daniela Rojas-Castro, Coalition Plus, Pantin, France |
|
0
09.00 am |
Treatment of HIV for Prevention: Reaching Full Potential
Myron Cohen
University of North Carolina, Chapel Hill, United States
|
|
0
09.20 am |
Past, Present and Future of PrEP
Jean-Michel Molina
University of Paris Cité, INSERM U944 and Department of Infectious Diseases, St-Louis and lariboisièr Hospitals, APHP, Paris, France
|
|
0
09.50 am |
Vaccine design to induce broadly neutralizing antibodies against HIV
William Schief
Scripps research, La Jolla, United States
|
|
0
10.10 am |
Vaccine Evaluation and Development in Africa : COVID-19 Pandemic Lessons for HIV Vaccine R&D
Glenda Elisabeth Gray
South African Medical Research Council (SAMRC), Cape Town, South Africa
|
|
| Coffee break |
| 10.30 am-11.00 am
|
|
|
| Session 6: New therapeutic strategy against HIV |
| 11.00 am-12.00 pm
|
| Chairs: Alexandra Calmy, Hopitaux universitaires de Genève, Geneva, Switzerland - Aahidjo Ayouba, Institut de Recherche pour le Développement, Montpellier, France |
|
0
11.00 am |
Novel antiretroviral therapies for people with HIV and why we need them
Joseph Eron
University of Chapel Hill, North Carolina, United States
|
|
0
11.20 am |
Therapeutic strategies in Africa: Could one size fit all?
Mireille Mpoudi-Etame
ANRS | EID, Yaounde, Cameroon
|
|
0
11.40 am |
CRISPR for the elimination of HIV-1
Kamel Khalili
Temple University, Philadelphia, United States
|
|
| Closing address |
| 12.00 pm-12.55 pm
|
|
|
0
12.00 pm |
Introduction
Jean-François Delfraissy
President of the French National Consultative Ethics Committee
|
|
0
12.10 pm |
HIV 40 years later, where are we going?
Françoise Barré-Sinoussi
Nobel Prize in Physiology or Medicine (2008), Institut Pasteur, Paris, France
|
|
0
12.40 pm |
Sylvie RETAILLEAU, ministre de l’Enseignement supérieur et de la Recherche
|
|
| End of meeting |
| 12.55 pm-2.15 pm
|
|
|
Persistance-webSoft
congresoft.frplateforme dédiée aux manifestations
Tel. : 01 84 17 20 55 / 06 89 19 34 06
E-mail : contact@congresoft.fr
La première plateforme Française de gestion de manifestations regroupant la billeterie, la gestion des hébergements, une boutique en ligne, la gestion des surfaces d'exposition et la gestion complète du programme scientifique.
Organisation de Congrès, manifestations, Séminiaires, Colloques
